Cargando…
Potential impact of a nonavalent anti HPV vaccine in Italian men with and without clinical manifestations
Human papilloma virus infection (HPV) is the most common sexually transmitted disease. Little is known about male infection. Nonavalent vaccine against types 6/11/16/18/31/33/45/52/58 was approved and neutral gender immunization programs have been proposed. This study evaluates the potential impact...
Autores principales: | Bosco, Liana, Serra, Nicola, Fasciana, Teresa, Pistoia, Daniela, Vella, Marco, Di Gregorio, Leonardo, Schillaci, Rosaria, Perino, Antonino, Calagna, Gloria, Firenze, Alberto, Capra, Giuseppina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892856/ https://www.ncbi.nlm.nih.gov/pubmed/33603082 http://dx.doi.org/10.1038/s41598-021-83639-6 |
Ejemplares similares
-
Potential impact of a nonavalent HPV vaccine on HPV related low-and high-grade cervical intraepithelial lesions: A referral hospital-based study in Sicily
por: Capra, Giuseppina, et al.
Publicado: (2017) -
Single-dose nonavalent HPV vaccine: Need of the hour
por: Pal, Manidip, et al.
Publicado: (2020) -
Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France
por: Riethmuller, Didier, et al.
Publicado: (2015) -
Cost-Effectiveness of Bivalent, Quadrivalent, and Nonavalent HPV Vaccination in South Africa
por: Michaeli, Daniel Tobias, et al.
Publicado: (2022) -
HPV infection in semen: results from a new molecular approach
por: Capra, G., et al.
Publicado: (2019)